Comparison of new hemostatic granules/powders with currently deployed hemostatic products in a lethal model of extremity arterial hemorrhage in swine.

BACKGROUND HemCon bandage (HC) and QuikClot granules (QC) have been deployed for the past 5 years for treating external hemorrhage in combat casualties. We examined efficacy and initial safety of three new hemostatic granules/powders in a swine extremity arterial hemorrhage model that was 100% fatal with army standard gauze treatment. The new products were compared with the most advanced forms of HC and QC products. METHODS Anesthetized pigs (37 kg, n = 46) were instrumented, splenectomized, and their femoral arteries were isolated and injured (6 mm arteriotomy). After 45 seconds free bleeding, a test agent [WoundStat (WS), super quick relief (SQR), Celox (CX)] or a control product [HC or QC bead bags (advanced clotting sponge plus)] was applied to the wounds and compressed with a large gauze for 2 minutes. Fluid resuscitation (colloid and crystalloid) was given and titrated to a mean arterial pressure of 65 mm Hg. Animals were observed for 180 minutes or until death. Computed tomography angiography was performed on survivors and tissue samples were collected form wounds for histologic examination. RESULTS No differences were found in baseline measurements and pretreatment blood loss (17.4 mL/kg +/- 0.5 mL/kg, mean +/- SEM) among groups. Advanced clotting sponge plus testing was halted after six unsuccessful attempts (no hemostasis observed) whereas other agents were tested each in 10 animals. Stable hemostasis was achieved in 10 (WS), 7 (SQR), 6 (CX), and 1 (HC) subjects in each group, resulting in the recovery of mean arterial pressure and survival of the animals for 3 hours (p < 0.05, SQR or WS vs. HC). Posttreatment blood loss was significantly reduced with the use of the new agents (CX = 40 +/- 16.6, SQR = 34.5 +/- 16.3, WS = 9.5 mL/kg +/- 5.2 mL/kg) as compared with HC (85.6 mL/kg +/- 10 mL/kg, p < 0.05). The granular treated animals lived for 180 (WS), 164 +/- 8.2 (SQR) and 138 +/- 17.7 (CX) minutes, significantly (p < 0.05) longer than the HC (83.3 +/- 12 minutes) group. A significant (p < 0.05) rise in temperature (53.5 degrees C +/- 1.8 degrees C) over baseline (36.5 degrees C +/- 0.3 degrees C) was measured only in the wounds treated with SQR. Computed tomography images showed no blood flow through treated vessels. Histologic evidence indicated the least tissue damage with HC, moderate damage with WS and CX, and most damage including axonal necrosis with SQR. CONCLUSION The new hemostatic agents are significantly more effective in treating arterial hemorrhage than currently deployed products. Among them, WS granules appear to be most efficacious, followed by SQR and CX powders. The clinical significance of tissue damage caused by these agents and any potential risk of embolism with procoagulant granular/powder products are unknown and warrant survival studies.

[1]  John B Holcomb,et al.  New hemostatic agents in the combat setting , 2009, Transfusion.

[2]  Ari Leppaniemi,et al.  A profile of combat injury. , 2003, The Journal of trauma.

[3]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[4]  P Hollingsworth-Fridlund,et al.  Lethal injuries and time to death in a level I trauma center. , 1998, Journal of the American College of Surgeons.

[5]  F. Godinez,et al.  An alternative hemostatic dressing: comparison of CELOX, HemCon, and QuikClot. , 2008, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[6]  Peter Rhee,et al.  Application of a zeolite hemostatic agent achieves 100% survival in a lethal model of complex groin injury in Swine. , 2004, The Journal of trauma.

[7]  S. Schwaitzberg,et al.  A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agent. , 1999, Surgery.

[8]  F. Lewis,et al.  Epidemiology of trauma deaths. , 1980, American journal of surgery.

[9]  K. Ryan,et al.  Application of a granular mineral-based hemostatic agent (QuikClot) to reduce blood loss after grade V liver injury in swine. , 2004, The Journal of trauma.

[10]  W. K. Prusaczyk,et al.  Comparative efficacy of granular and bagged formulations of the hemostatic agent QuikClot. , 2007, The Journal of trauma.

[11]  J. Holcomb,et al.  Comparison of hemorrhage control agents applied to lethal extremity arterial hemorrhages in swine. , 2005, The Journal of trauma.

[12]  P. Rhee,et al.  Intracorporeal use of the hemostatic agent QuickClot in a coagulopathic patient with combined thoracoabdominal penetrating trauma. , 2004, The Journal of trauma.

[13]  Lisa Pearse,et al.  Injury severity and causes of death from Operation Iraqi Freedom and Operation Enduring Freedom: 2003-2004 versus 2006. , 2008, The Journal of trauma.

[14]  Rolf Lefering,et al.  Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. , 2006, The Journal of trauma.

[15]  Peter Rhee,et al.  Comparative analysis of hemostatic agents in a swine model of lethal groin injury. , 2003, The Journal of trauma.

[16]  Anthony E. Pusateri,et al.  The Chitosan-Based Hemostatic Dressing: Experience in Current Combat Operations. , 2005, The Journal of trauma.

[17]  G. Bowlin,et al.  Comparison of a New Hemostatic Agent to Current Combat Hemostatic Agents in a Swine Model of Lethal Extremity Arterial Hemorrhage , 2007 .

[18]  A. Sauaia,et al.  Epidemiology of trauma deaths: a reassessment. , 1993, The Journal of trauma.

[19]  R. Bellamy The causes of death in conventional land warfare: implications for combat casualty care research. , 1984, Military medicine.

[20]  Richard A. Harris,et al.  Effect of a chitosan-based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine. , 2003, The Journal of trauma.

[21]  Peter Rhee,et al.  QuikClot use in trauma for hemorrhage control: case series of 103 documented uses. , 2008, The Journal of trauma.